Share SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing Agreement

GlobeNewsWire · GTLL · November 20, 2026

SRX Global Provides Update on Engineered T-Cell Strategy Following Pfizer–Starna Licensing Agreement

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: GlobeNewsWire ↗